1671.0000 -1.50 (-0.09%)
NSE Jul 09, 2025 11:35 AM
Volume: 600.7K
 

1671.00
-0.09%
Motilal Oswal
Sun Pharmaceutical Industries (SUNP) delivered 4%/9%/4% miss on revenue/EBITDA/PAT for 4QFY25. Lower-than-expected sales in global specialty and ROW led to a miss on 4QFY25 performance.
Promoters pledged 0.19% of shares in last quarter. Total pledge stands at 0.88% of promoter holdings
More from Sun Pharmaceutical Industries Ltd.
Recommended